The first-choice treatment for aplastic anemia is bone marrow transplant with a sibling donor who is human lymphocyte antigens (HLA) matched.
再障的首选治疗是人淋巴细胞抗原相配的同胞姊妹骨髓移植。
2
Three-dimensional structure modeling of HLA-Aantigens for predicting GVHD occurrence is one of the important progress in the field of transplant immunology.